0001713836-19-000001.txt : 20190417 0001713836-19-000001.hdr.sgml : 20190417 20190416183635 ACCESSION NUMBER: 0001713836-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190417 DATE AS OF CHANGE: 20190416 EFFECTIVENESS DATE: 20190417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neuraptive Therapeutics, Inc. CENTRAL INDEX KEY: 0001713836 IRS NUMBER: 821914769 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-337525 FILM NUMBER: 19751885 BUSINESS ADDRESS: STREET 1: 2697 TRAILRIDGE DR WEST CITY: LAFAYETTE STATE: CO ZIP: 80026 BUSINESS PHONE: 303-736-9657 MAIL ADDRESS: STREET 1: PO BOX 3441 CITY: WINTER PARK STATE: CO ZIP: 80482 D 1 primary_doc.xml X0708 D LIVE 0001713836 Neuraptive Therapeutics, Inc. 168 CTC Blvd Louisville CO COLORADO 80027 303-736-9657 DELAWARE None None Corporation true 2017 David Jackson 168 CTC Blvd Louisville CO COLORADO 80027 Executive Officer Director Gino DiSciullo 2697 W. Trailridge Dr. Lafayette CO COLORADO 80026 Director Greg Parekh Two Logan Square, 100 N. 18th Street Suite 1930 Philadelphia PA PENNSYLVANIA 19103 Director Ivan Gergel Two Logan Square, 100 N. 18th Street Suite 1930 Philadelphia PA PENNSYLVANIA 19103 Director Randy Hubbell 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Director Biotechnology Decline to Disclose 06b false 2018-12-18 false true false 0 12499998 10224998 2275000 false 5 0 0 0 false Neuraptive Therapeutics, Inc. David M. Jackson David M. Jackson Chief Executive Officer 2019-04-16